Go online to PeerView.com/MVH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, experts in SSc-ILD discuss how to accurately interpret HRCT patterns, the latest diagnosis and management guidelines, including the importance of identifying and treating comorbidities, and the efficacy and safety of novel and emerging therapies. Upon completion of this CE activity, participants will be able to: Recognize signs, symptoms, and HRCT patterns indicative of ILD in patients with SSc and the importance of regular pulmonary monitoring in patients with SSc, Employ the latest guideline recommendations to the diagnosis and management of SSc-ILD in the context of an interprofessional approach, Apply the latest clinical evidence regarding efficacy and safety on novel and emerging therapies, including antifibrotic agents, to the treatment of SSc-ILD, Discuss the importance of assessing and managing comorbidities, such as gastroesophageal reflux disease and sleep apnea, in patients with SSc-ILD.